Vanguard Group’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
3,280,709
+786,564
| +32% | +$3.15M | ﹤0.01% | 2757 |
|
|
2025
Q1 | $7.93M | Buy |
2,494,145
+39,549
| +2% | +$126K | ﹤0.01% | 2972 |
|
|
2024
Q4 | $13.1M | Buy |
2,454,596
+33,977
| +1% | +$182K | ﹤0.01% | 2802 |
|
|
2024
Q3 | $12.8M | Buy |
2,420,619
+770,119
| +47% | +$4.07M | ﹤0.01% | 2834 |
|
|
2024
Q2 | $3M | Buy |
1,650,500
+157,143
| +11% | +$286K | ﹤0.01% | 3433 |
|
|
2024
Q1 | $2.66M | Buy |
1,493,357
+142,724
| +11% | +$254K | ﹤0.01% | 3503 |
|
|
2023
Q4 | $2.38M | Buy |
1,350,633
+3,701
| +0.3% | +$6.51K | ﹤0.01% | 3544 |
|
|
2023
Q3 | $1.97M | Buy |
1,346,932
+45,707
| +4% | +$66.7K | ﹤0.01% | 3586 |
|
|
2023
Q2 | $2.98M | Buy |
1,301,225
+40,659
| +3% | +$93.1K | ﹤0.01% | 3525 |
|
|
2023
Q1 | $1.15M | Hold |
1,260,566
| – | – | ﹤0.01% | 3876 |
|
|
2022
Q4 | $1.07M | Buy |
1,260,566
+660
| +0.1% | +$561 | ﹤0.01% | 3892 |
|
|
2022
Q3 | $1.03M | Sell |
1,259,906
-7,846
| -0.6% | -$6.42K | ﹤0.01% | 3989 |
|
|
2022
Q2 | $1.26M | Hold |
1,267,752
| – | – | ﹤0.01% | 4010 |
|
|
2022
Q1 | $2.08M | Buy |
1,267,752
+36,002
| +3% | +$59K | ﹤0.01% | 3938 |
|
|
2021
Q4 | $2.97M | Buy |
1,231,750
+28,387
| +2% | +$68.4K | ﹤0.01% | 3873 |
|
|
2021
Q3 | $5.82M | Buy |
1,203,363
+94,145
| +8% | +$456K | ﹤0.01% | 3561 |
|
|
2021
Q2 | $2.96M | Buy |
1,109,218
+109,099
| +11% | +$291K | ﹤0.01% | 3841 |
|
|
2021
Q1 | $3.08M | Buy |
1,000,119
+356,539
| +55% | +$1.1M | ﹤0.01% | 3748 |
|
|
2020
Q4 | $2.29M | Buy |
643,580
+37,466
| +6% | +$133K | ﹤0.01% | 3627 |
|
|
2020
Q3 | $2.43M | Buy |
606,114
+31,887
| +6% | +$128K | ﹤0.01% | 3433 |
|
|
2020
Q2 | $1.56M | Hold |
574,227
| – | – | ﹤0.01% | 3505 |
|
|
2020
Q1 | $1.21M | Hold |
574,227
| – | – | ﹤0.01% | 3438 |
|
|
2019
Q4 | $3.12M | Buy |
574,227
+136
| +0% | +$740 | ﹤0.01% | 3320 |
|
|
2019
Q3 | $1.73M | Buy |
574,091
+86,455
| +18% | +$260K | ﹤0.01% | 3493 |
|
|
2019
Q2 | $1.82M | Buy |
487,636
+28,239
| +6% | +$106K | ﹤0.01% | 3501 |
|
|
2019
Q1 | $1.85M | Buy |
459,397
+226,628
| +97% | +$911K | ﹤0.01% | 3476 |
|
|
2018
Q4 | $855K | Sell |
232,769
-445,205
| -66% | -$1.64M | ﹤0.01% | 3612 |
|
|
2018
Q3 | $5.82M | Buy |
677,974
+13,578
| +2% | +$116K | ﹤0.01% | 3175 |
|
|
2018
Q2 | $7.3M | Buy |
664,396
+53,375
| +9% | +$586K | ﹤0.01% | 3053 |
|
|
2018
Q1 | $7.05M | Buy |
611,021
+224,849
| +58% | +$2.59M | ﹤0.01% | 2993 |
|
|
2017
Q4 | $4M | Buy |
386,172
+19
| +0% | +$197 | ﹤0.01% | 3211 |
|
|
2017
Q3 | $6.16M | Buy |
386,153
+12,641
| +3% | +$201K | ﹤0.01% | 3031 |
|
|
2017
Q2 | $4.52M | Buy |
373,512
+101,013
| +37% | +$1.22M | ﹤0.01% | 3118 |
|
|
2017
Q1 | $5.66M | Buy |
272,499
+16,104
| +6% | +$334K | ﹤0.01% | 3012 |
|
|
2016
Q4 | $3.67M | Buy |
256,395
+36,085
| +16% | +$516K | ﹤0.01% | 3167 |
|
|
2016
Q3 | $3.62M | Buy |
220,310
+53,513
| +32% | +$880K | ﹤0.01% | 3150 |
|
|
2016
Q2 | $2.38M | Buy |
+166,797
| New | +$2.38M | ﹤0.01% | 3318 |
|